Drug Database
Back to search

Finland· FI-REL-REL60986

Nintedanib Sandoz

A nintedanib product containing nintedanib esylate, registered in Finland by Sandoz A/S. The same ATC class is registered in 14 of our 19 countries.

ATC L01EX09

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedNintedanib SandozATCL01EX09REGISTER NO.FI-REL-REL60986PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about nintedanib esylateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Nintedanib is registered in 14 of 19 countries.

Countries holding a registration under ATC L01EX09 (nintedanib), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 7 of them publish a price we can compare per daily dose
Search nintedanib products by name

Nintedanib · ATC L01EX09

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of nintedanib costs, country by country.

Normalised to the WHO defined daily dose (0.38 g), so markets compare like for like.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Nintedanib · price per daily dose (0.38 g)

USD · FX 28 Sept 2026

  • US United States$51.13 (acquisition cost)
  • CH Switzerland$34.12
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

Fimea (Finland)
Active substance
Nintedanib esylate
Manufacturer
Sandoz A/S
Country
Finland (FI)
ATC code
L01EX09
ATC class
Nintedanib
Defined daily dose
0.38 g, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 1

1 priced
  • fi_myyntilupa
    112362
    60 x 1
    EUR 369.53

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

160 interactions on record for nintedanib.

Graded by severity as the source publishes them — 21 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check nintedanib against other medicinesHow interaction checks work

Nintedanib · interactions on record

160 records

  • 21 severe
  • 139 moderate

Most severe, free to view

  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • DexamethasoneH02AB02severe
  • RifampicinJ04AB02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Nintedanib in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All nintedanib products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

  • Austria · Nintedanib Accordpharma, Nintedanib Ratiopharm
  • Cyprus · Nintedanib Teva
  • Germany · Nintedanib Al, Nintedanib Ipf Al
  • Denmark · Nintedanib Bioglan, Nintedanib Teva
  • Estonia · Nintedanib Stada
  • United Kingdom (Northern Ireland) · Nintedanib, Nintedanib Eugia (Uk)
  • Hungary · Lunidoc
  • Iceland · Nintedanib Demo
  • Luxembourg · Nintedanib Teva
  • Netherlands · Nintedanib Reig Jofre, Nintedanib Tillomed
  • Norway · Nintedanib Zentiva
  • Portugal · Nintedanib Bravet, Nintedanib Teva Pharma
  • Romania · Gevesla, Nintedanib Teva
  • Sweden · Nintedanib Bioglan, Nintedanib Teva Gmbh
  • Slovakia · Gevesla

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/da7a5ab6-a4eb-48a0-b0bc-684c46c26dd4
GET /v1/drugs/da7a5ab6-a4eb-48a0-b0bc-684c46c26dd4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "0.38",
  "form": "kapseli, pehmeä",
  "route": "Suun kautta",
  "ddd_unit": "g",
  "strength": "150 mg",
  "atc_label": "nintedanibi",
  "ma_number": "41925",
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": null,
  "fimea_rel_id": "REL60986",
  "authorised_at": "2024-11-08"
}
API referenceMCP serverPlans

See everything about nintedanib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console